Top news of the week: 02.05.2022.
Healthcare
How Paxlovid came to be: From the germ of an idea to a vital tool against Covid
The story of Paxlovid is a reminder that the path from a biological idea to a useable medicine depends on thousands of decisions, any of which can result in the medicine not making it.
In a surprise move, Novartis CEO Vas Narasimhan recruits top analyst Ronny Gal as new strategy, BD chief
After a long run observing Novartis and the rest of the Big Pharma world as a top analyst, Bernstein’s Ronny Gal will now move into the upper echelon of the Swiss giant’s executive crew to ...
OICR-JLABS cancer symposium series
May 12, 2022, 1-2:30 p.m. ET Cell and gene therapies have revolutionized how we treat blood cancers, but therapies aimed at solid cancers have not had the same success. On May 12, join the ...
Patients Look Beyond the Pandemic to Pharma for Engagement, Innovation, and Integrity
The COVID-19 pandemic has impacted patients who were already deeply engaged with their own health care before the coronavirus emerged. Compared with a year ago, more patients and their ...
SECURITIES AND EXCHANGE COMMISSION
Consolidated Statement of Operations Data: 2021 2020 Revenues $ - $ 35,470 Research and development 768,621 571,738 General and administrative 2,668,311 2,673,445 Total operating …
Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants
SARS-CoV-2 neutralizing antibodies are readily detected with a biosensor.
Battle scars: The journey from lab to patient’s bedside
Whether it’s in the initial R&D, or during the final manufacturing process, taking a drug from a mere concept to a tangible solution is not without
PureTech Announces Annual Results for Year Ended December 31, 2021
RNS Number : 2853J PureTech Health PLC 26 April 2022 26 April 2022 PureTech Health plc PureTech Announces Annual Results for Year Ended December 31, 2021 Strong capital base with PureTech ...